SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021854
Filing Date
2022-11-03
Accepted
2022-11-03 16:08:24
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20220930.htm   iXBRL 10-Q 3670104
2 EX-31.1 vir-ex31_1.htm EX-31.1 22675
3 EX-31.2 vir-ex31_2.htm EX-31.2 22674
4 EX-32.1 vir-ex32_1.htm EX-32.1 15022
  Complete submission text file 0000950170-22-021854.txt   11998566

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20220930.xsd EX-101.SCH 93685
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20220930_pre.xml EX-101.PRE 469372
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20220930_lab.xml EX-101.LAB 650897
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20220930_cal.xml EX-101.CAL 64029
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20220930_def.xml EX-101.DEF 337332
60 EXTRACTED XBRL INSTANCE DOCUMENT vir-20220930_htm.xml XML 2062031
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 221358008
SIC: 2836 Biological Products, (No Diagnostic Substances)